Results 141 to 150 of about 1,028,562 (262)

From Expectation to Learning: A Mediational Model of Exposure Therapy Outcome in Anxiety Disorders.

Psychother Psychosom
Straube B, Kirchner L, Haccou GL, Ridderbusch IC, Heinig I, Richter J, Lueken U, Pauli P, Deckert J, Domschke K, Neudeck P, Koelkebeck K, Dannlowski U, Arolt V, Fydrich T, Ströhle A, Margraf J, Schneider S, Hoyer J, Hamm AO, Wittchen HU, Kircher T, Rief W, Pittig A.   +23 more
europepmc   +1 more source

Innovative virtual reality exposure therapy for anxiety and posttraumatic stress disorder: a meta-analysis of randomised controlled trials. [PDF]

J Glob Health
Chang YC, Arifin H, Hung TM, Lin CL, Ye JY, Pien LC, Su PY, Chen R, Chou KR.   +8 more
europepmc   +1 more source

Functional and Structural Evidence of Neurofluid Circuit Aberrations in Huntington Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Disrupted neurofluid regulation may contribute to neurodegeneration in Huntington disease (HD). Because neurofluid pathways influence waste clearance, inflammation, and the distribution of central nervous system (CNS)–delivered therapeutics, understanding their dysfunction is increasingly important as targeted treatments emerge.
Kilian Hett, Abigail Dubois, Melanie Leguizamon, Alexander Song, Paula Trujillo, Colin D. McKnight, Ciaran M. Considine, Manus J. Donahue, Daniel O. Claassen   +8 more
wiley   +1 more source

Mobile App-Guided Exposure Therapy for Panic Disorder With and Without Agoraphobia: Randomized Controlled Trial. [PDF]

J Med Internet Res
Guth M, Wiebe A, Ekhlas-Schumann M, Rodenjohann A, Rohlfsen F, Buchholz J, Selaskowski B, Philipsen A, Braun N.   +8 more
europepmc   +1 more source

Vestibular Patient Journey: Insights From Vestibular Disorders Association (VeDA) Registry

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Vestibular symptoms impose a high burden of disability. Understanding real‐world diagnostic and treatment pathways can identify care gaps and guide interventions. We aimed to characterize symptom profiles, diagnostic trends, provider involvement, and treatment patterns in vestibular disorders.
Ali Rafati, Sami I. Nassar, Shaun A. Nguyen, Patricia L. Gerend, Michael C. Schubert, Michael T. Teixido, Frederick A. Godley, Joel A. Goebel, Cynthia A. Ryan, Habib G. Rizk, Amir Kheradmand   +10 more
wiley   +1 more source

Detecting neurobiological markers in treatment response to prolonged exposure therapy for PTSD: An RCT using functional near-infrared spectroscopy. [PDF]

MethodsX
Booysen DD, Zondo S.
europepmc   +1 more source

A Prospective Study of Individuals at Risk of Multiple Sclerosis Informs the Design of Primary Prevention Studies

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective In multiple sclerosis, the optimal time for deploying a therapeutic intervention is before the central nervous system is damaged; given the success of trials treating the earliest stage of MS, the radiologically isolated syndrome, developing primary prevention strategies is an important next challenge.
Amy W. Laitinen, Ceren Tozlu, Tina Roostaei, Fatoumata Diallo, Kaho Onomichi, Jiyeon Son, Zongqi Xia, Philip L. De Jager   +7 more
wiley   +1 more source

Integrating Artificial Intelligence Into Exposure Therapy: A One Year Follow-Up Case Report of Emetophobia With Comorbid Panic Disorder. [PDF]

Clin Case Rep
Kilic US.
europepmc   +1 more source

A Systematic Review and Meta‐Analysis of the Recurrence of Autoimmune Encephalitis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autoimmune encephalitis (AE) is a disease with a potential for recurrence, and patients receive immunotherapy to prevent it. However, there is no consensus on the duration of immunotherapy. This study aimed to determine the recurrence rate and identify the risk factors for AE to provide guidance on the duration of immunotherapy ...
Shangkai Bai, Sen Zhang, Haipei Zhang, Yating Zhang, Junhong Guo, Xiaoyan Yang   +5 more
wiley   +1 more source

Basic emotions reported by individuals with persistent physical symptoms receiving exposure therapy versus healthy lifestyle promotion in primary care. [PDF]

Sci Rep
Hybelius J, Af Winklerfelt Hammarberg S, Salomonsson S, Wachtler C, Epstein M, Olsson A, Strand E, Söderström Winter L, Ahnlund Hoffmann A, Spansk E, Åkerlund T, Björkander D, Kosic A, Chahin G, Wallert J, Toth-Pal E, Nordin S, Witthöft M, Axelsson E.   +18 more
europepmc   +1 more source